Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis - PubMed (original) (raw)
Review
. 2016 Nov;61(11):3321-3334.
doi: 10.1007/s10620-016-4260-9. Epub 2016 Jul 25.
Affiliations
- PMID: 27456504
- DOI: 10.1007/s10620-016-4260-9
Review
Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis
Feifei Hou et al. Dig Dis Sci. 2016 Nov.
Abstract
Background: Hepatic hydrothorax (HH) is a serious complication of end-stage liver diseases, which is associated with poor survival. There is no consensus regarding the treatment of HH.
Aim: To evaluate the effectiveness and safety of pleurodesis for HH in a systematic review with meta-analysis.
Methods: All relevant papers were searched on the EMBASE and PubMed databases. As for the data from the eligible case reports, the continuous data were expressed as the median (range) and the categorical data were expressed as the frequency (percentage). As for the data from the eligible case series, the rates of complete response and complications were pooled. The proportions with 95 % confidence intervals (CIs) were calculated by using random-effect model.
Results: Twenty case reports including 26 patients and 13 case series including 180 patients were eligible. As for the case reports, the median age was 55 years (range 7-78) and 15 patients were male. The prevalence of ascites was 76 % (19/25). Seventeen (65.38 %) patients responded favorably to pleurodesis. As for the case series, the mean age was 51.5-63.0 years and 83 patients were male. The pooled prevalence of ascites was 90 % (95 % CI 81-97 %) in 7 studies including 71 patients. The complete response rate after pleurodesis was reported in all studies, and the pooled rate was 72 % (95 % CI 65-79 %). Complications related to pleurodesis were reported in 6 studies including 63 patients, and the pooled rate was 82 % (95 % CI 66-94 %).
Conclusion: Pleurodesis may be a promising treatment for HH, but carries a high rate of complications.
Keywords: Hepatic hydrothorax; Liver cirrhosis; Pleural effusion; Pleurodesis; Portal hypertension.
Similar articles
- Hepatic hydrothorax in the absence of ascites in a child with autoimmune hepatitis: Successful management with octreotide and pleurodesis.
Sıra MM, Sıra AM, Behairy Bel-S, Bakır RM, El-Hagaly MA. Sıra MM, et al. Turk J Gastroenterol. 2013;24(2):174-83. Turk J Gastroenterol. 2013. PMID: 23934468 - Impact of therapeutic interventions on survival of patients with hepatic hydrothorax.
Liu WL, Kuo PH, Ku SC, Huang PM, Yang PC. Liu WL, et al. J Formos Med Assoc. 2010 Aug;109(8):582-8. doi: 10.1016/S0929-6646(10)60095-2. J Formos Med Assoc. 2010. PMID: 20708509 - Mechanical pleurodesis aided by peritoneal drainage: procedure for hepatic hydrothorax.
Northup PG, Harmon RC, Pruett TL, Schenk WG 3rd, Daniel TM, Berg CL. Northup PG, et al. Ann Thorac Surg. 2009 Jan;87(1):245-50. doi: 10.1016/j.athoracsur.2008.10.013. Ann Thorac Surg. 2009. PMID: 19101306 - Hepatic hydrothorax.
Krok KL, Cárdenas A. Krok KL, et al. Semin Respir Crit Care Med. 2012 Feb;33(1):3-10. doi: 10.1055/s-0032-1301729. Epub 2012 Mar 23. Semin Respir Crit Care Med. 2012. PMID: 22447255 Review. - Hepatic hydrothorax: current concepts of pathophysiology and treatment options.
Kiafar C, Gilani N. Kiafar C, et al. Ann Hepatol. 2008 Oct-Dec;7(4):313-20. Ann Hepatol. 2008. PMID: 19034230 Review.
Cited by
- Medical thoracoscopy with talc pleurodesis for refractory hepatic hydrothorax: A case series of three successes.
Rahim Y, Reddy RV, Naeem M, Tsaknis G. Rahim Y, et al. Respir Med Case Rep. 2024 May 16;50:102039. doi: 10.1016/j.rmcr.2024.102039. eCollection 2024. Respir Med Case Rep. 2024. PMID: 38817846 Free PMC article. - Hepatic hydrothorax.
Wilkins H, Britt E, Bhatnagar M, Pippard B. Wilkins H, et al. J Thorac Dis. 2024 Feb 29;16(2):1662-1673. doi: 10.21037/jtd-23-1649. Epub 2024 Feb 23. J Thorac Dis. 2024. PMID: 38505059 Free PMC article. Review. - Pulmonary Assessment of the Liver Transplant Recipient.
Panackel C, Fawaz M, Jacob M, Raja K. Panackel C, et al. J Clin Exp Hepatol. 2023 Sep-Oct;13(5):895-911. doi: 10.1016/j.jceh.2023.04.003. Epub 2023 Apr 18. J Clin Exp Hepatol. 2023. PMID: 37693254 Free PMC article. Review. - Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).
Mandorfer M, Aigner E, Cejna M, Ferlitsch A, Datz C, Gräter T, Graziadei I, Gschwantler M, Hametner-Schreil S, Hofer H, Jachs M, Loizides A, Maieron A, Peck-Radosavljevic M, Rainer F, Scheiner B, Semmler G, Reider L, Reiter S, Schoder M, Schöfl R, Schwabl P, Stadlbauer V, Stauber R, Tatscher E, Trauner M, Ziachehabi A, Zoller H, Fickert P, Reiberger T. Mandorfer M, et al. Wien Klin Wochenschr. 2023 Sep;135(Suppl 3):493-523. doi: 10.1007/s00508-023-02229-w. Epub 2023 Jun 26. Wien Klin Wochenschr. 2023. PMID: 37358642 Free PMC article. - Asia-Pacific association for study of liver guidelines on management of ascites in liver disease.
Singh V, De A, Mehtani R, Angeli P, Maiwall R, Satapathy S, Singal AK, Saraya A, Sharma BC, Eapen CE, Rao PN, Shukla A, Shalimar, Choudhary NS, Alcantara-Payawal D, Arora V, Aithal G, Kulkarni A, Roy A, Shrestha A, Mamun Al Mahtab, Niriella MA, Siam TS, Zhang CQ, Huei LG, Yu ML, Roberts SK, Peng CY, Chen T, George J, Wong V, Yilmaz Y, Treeprasertsuk S, Kurniawan J, Kim SU, Younossi ZM, Sarin SK. Singh V, et al. Hepatol Int. 2023 Aug;17(4):792-826. doi: 10.1007/s12072-023-10536-7. Epub 2023 May 26. Hepatol Int. 2023. PMID: 37237088 No abstract available.
References
- Am J Med. 1999 Sep;107(3):262-7 - PubMed
- ScientificWorldJournal. 2011 Mar 07;11:587-91 - PubMed
- Chest. 1994 Dec;106(6):1771-5 - PubMed
- Ann Thorac Surg. 1997 Nov;64(5):1468-9 - PubMed
- Magn Reson Imaging. 2004 Apr;22(3):431-3 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials